# Bioavailability of Intranasal Dexmedetomidine

> **NCT05065775** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 30 (actual)

## Conditions studied

- Pharmacokinetics
- Arthritis Knee
- Arthritis of Hip
- Anesthesia

## Interventions

- **DEVICE:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT05065775
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-05-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065775, "Bioavailability of Intranasal Dexmedetomidine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05065775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*